Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samuel T Wilkinson

Showing results (61-70 of 103) with videos related to

Pageof 11
Sort By:
The American Journal of Psychiatry|September 10, 2021
Association of ECT With Risks of All-Cause Mortality and Suicide in Older Medicare PatientsTaeho Greg Rhee, Kyaw Sint, Mark Olfson, et al.
The Journal of ECT|June 14, 2019
A Measure to Assess Perceptions and Knowledge About Electroconvulsive Therapy: Development and Psychometric PropertiesJack Tsai, Minda Huang, Samuel T Wilkinson, et al.
The Journal of Clinical Psychiatry|October 3, 2024
Efficacy and Safety of Ketamine/Esketamine in Bipolar Depression in a Clinical SettingMia C Santucci, Mina Ansari, Sina Nikayin, et al.
The American Journal of Psychiatry|July 4, 2017
A Survey of the Clinical, Off-Label Use of Ketamine as a Treatment for Psychiatric DisordersSamuel T Wilkinson, Mesut Toprak, Mason S Turner, et al.
The Journal of Clinical Psychiatry|September 16, 2021
Mental Health Care Resource Utilization and Barriers to Receiving Mental Health Services Among US Adults With a Major Depressive Episode and Suicidal Ideation or Behavior With IntentJennifer Voelker, Qian Cai, Ella Daly, et al.
The American Journal of Psychiatry|September 10, 2025
Ketamine for Depression, but at What Cost? A Review of Ketamine's Neurotoxic Effects From Preclinical and Human StudiesS William Li, Kristina T Kumpf, Julian Urrutia, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|March 25, 2017
Ketamine as a Treatment for Adolescent Depression: A Case ReportJennifer B Dwyer, Chad Beyer, Samuel T Wilkinson, et al.
BMJ Mental Health|December 17, 2025
Longitudinal associations of electroconvulsive therapy with all-cause mortality and suicide deaths in severe unipolar or bipolar depression: a systematic review and meta-analysisTaeho Greg Rhee, Sungryul Shim, Madeeha Nasir, et al.
Psychotherapy and Psychosomatics|May 11, 2017
Cognitive Behavior Therapy May Sustain Antidepressant Effects of Intravenous Ketamine in Treatment-Resistant DepressionSamuel T Wilkinson, DaShaun Wright, Madonna K Fasula, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2023
Ketamine and the neurobiology of depression: Toward next-generation rapid-acting antidepressant treatmentsJohn H Krystal, Alfred P Kaye, Sarah Jefferson, et al.
Pageof 11

Showing results (61-70 of 103) with videos related to

Sort By:
Pageof 11
The American Journal of Psychiatry|September 10, 2021
Association of ECT With Risks of All-Cause Mortality and Suicide in Older Medicare PatientsTaeho Greg Rhee, Kyaw Sint, Mark Olfson, et al.
The Journal of ECT|June 14, 2019
A Measure to Assess Perceptions and Knowledge About Electroconvulsive Therapy: Development and Psychometric PropertiesJack Tsai, Minda Huang, Samuel T Wilkinson, et al.
The Journal of Clinical Psychiatry|October 3, 2024
Efficacy and Safety of Ketamine/Esketamine in Bipolar Depression in a Clinical SettingMia C Santucci, Mina Ansari, Sina Nikayin, et al.
The American Journal of Psychiatry|July 4, 2017
A Survey of the Clinical, Off-Label Use of Ketamine as a Treatment for Psychiatric DisordersSamuel T Wilkinson, Mesut Toprak, Mason S Turner, et al.
The Journal of Clinical Psychiatry|September 16, 2021
Mental Health Care Resource Utilization and Barriers to Receiving Mental Health Services Among US Adults With a Major Depressive Episode and Suicidal Ideation or Behavior With IntentJennifer Voelker, Qian Cai, Ella Daly, et al.
The American Journal of Psychiatry|September 10, 2025
Ketamine for Depression, but at What Cost? A Review of Ketamine's Neurotoxic Effects From Preclinical and Human StudiesS William Li, Kristina T Kumpf, Julian Urrutia, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|March 25, 2017
Ketamine as a Treatment for Adolescent Depression: A Case ReportJennifer B Dwyer, Chad Beyer, Samuel T Wilkinson, et al.
BMJ Mental Health|December 17, 2025
Longitudinal associations of electroconvulsive therapy with all-cause mortality and suicide deaths in severe unipolar or bipolar depression: a systematic review and meta-analysisTaeho Greg Rhee, Sungryul Shim, Madeeha Nasir, et al.
Psychotherapy and Psychosomatics|May 11, 2017
Cognitive Behavior Therapy May Sustain Antidepressant Effects of Intravenous Ketamine in Treatment-Resistant DepressionSamuel T Wilkinson, DaShaun Wright, Madonna K Fasula, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2023
Ketamine and the neurobiology of depression: Toward next-generation rapid-acting antidepressant treatmentsJohn H Krystal, Alfred P Kaye, Sarah Jefferson, et al.
Pageof 11